L-tyrosine could help treat Nemaline Myopathy in children

Published on November 23, 2011 at 12:30 AM · 2 Comments

Common amino acid used by body builders could be the key to beating common form of muscular dystrophy

A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.

The amino acid L-tyrosine had a "rapid and dramatic impact" on Nemaline Myopathy (NM) in laboratory tests on mice, significantly improving symptoms of the muscle-wasting disease, medical researchers from the University of New South Wales (UNSW) found.

Trials showed that consuming L-tyrosine could significantly improve muscle strength and mobility in NM, raising the possibility it also could be effective in a range of other muscle-wasting diseases. L-tyrosine is readily available in health food shops for less than $30 and is used as a body building supplement and as a memory booster.

There is currently no cure for NM (or Rod Myopathy) - the most common congenital muscle disease - which causes muscle weakness of varying severity in an estimated 500 Australian children.

Children with NM experience delayed motor development and weakness in the arms and legs, trunk, throat and face muscles. The condition can lead to difficulties breathing and moving and, in its severest form, can cause death.

A team of scientists led by Professor Edna Hardeman, from UNSW's Neuromuscular and Regenerative Medicine Unit, were able to test the efficacy of the supplement after creating - for the first time - a genetically modified mouse which display the same genetic changes found in children with NM.

"These mice and have a remarkably similar disease profile to the children, with many of the animals dying young," Professor Hardeman said.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
  1. Gino Moonsamy Gino Moonsamy South Africa says:

    My daughter was diagonised with nemaline rod myopathy since birth. She is now 11 years old. My wife and i are seriously considering supplementing our daughter with L- Tyrosine. We aim to start this before the end of 2012.

    • Sara Sara Germany says:

      Hi,
      i have a friend in london who has also had nemaline myopathy since birth. she is 16 years old and really wants to have this treatment but the doctors are not willing to try until some time in 2013, but if the family hear positive feedback then they would like to start now. Please be in touch if you know more on the subject or if you know who i could contact who has experience in l- tyrosine.
      Many thanks
      Sara

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post